These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis. Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274 [TBL] [Abstract][Full Text] [Related]
4. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899 [TBL] [Abstract][Full Text] [Related]
5. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221 [TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas. Yao R; Cheng A; Liu M; Zhang Z; Jin B; Yu H J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):269-276. PubMed ID: 33346568 [TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices. Rani N; Singh B; Kumar N; Singh P; Hazari PP; Jaswal A; Gupta SK; Chhabra R; Radotra BD; Mishra AK Nucl Med Commun; 2020 Sep; 41(9):848-857. PubMed ID: 32796472 [TBL] [Abstract][Full Text] [Related]
9. Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade. Sahin N; Melhem ER; Wang S; Krejza J; Poptani H; Chawla S; Verma G Neuroradiol J; 2013 Oct; 26(5):531-41. PubMed ID: 24199813 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading. Tran D; Nguyen DH; Nguyen HK; Nguyen-Thanh VA; Dong-Van H; Nguyen MD Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7938-7948. PubMed ID: 36394742 [TBL] [Abstract][Full Text] [Related]
11. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy. Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707 [TBL] [Abstract][Full Text] [Related]
12. The utility of magnetic resonance spectroscopy in frame-less stereotactic needle biopsy of glioma. Wang Q; Zhang J; Li F; Chen X; Xu B J Clin Neurosci; 2021 Jun; 88():102-107. PubMed ID: 33992167 [TBL] [Abstract][Full Text] [Related]
13. The role of 3-Tesla magnetic resonance perfusion and spectroscopy in distinguishing glioblastoma from solitary brain metastasis. Hung ND; Dung LV; Vi NH; Hai Anh NT; Hong Phuong LT; Hieu ND; Duc NM J Clin Imaging Sci; 2023; 13():19. PubMed ID: 37559877 [TBL] [Abstract][Full Text] [Related]
14. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868 [TBL] [Abstract][Full Text] [Related]
15. Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics. Usinskiene J; Ulyte A; Bjørnerud A; Venius J; Katsaros VK; Rynkeviciene R; Letautiene S; Norkus D; Suziedelis K; Rocka S; Usinskas A; Aleknavicius E Neuroradiology; 2016 Apr; 58(4):339-50. PubMed ID: 26767528 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience. Anselmi M; Catalucci A; Felli V; Vellucci V; Di Sibio A; Gravina GL; Di Staso M; Di Cesare E; Masciocchi C Neuroradiol J; 2017 Jun; 30(3):240-252. PubMed ID: 28627984 [TBL] [Abstract][Full Text] [Related]
17. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas. Ankush A; Sardessai S Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207 [TBL] [Abstract][Full Text] [Related]
18. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection. Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387 [TBL] [Abstract][Full Text] [Related]
19. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging. Lin K; Cidan W; Qi Y; Wang X Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379 [TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI in differentiating solitary brain metastasis from high-grade glioma: diagnostic value of the combined use of diffusion-weighted imaging, dynamic susceptibility contrast imaging, and magnetic resonance spectroscopy parameters. Aslan K; Gunbey HP; Tomak L; Incesu L Neurol Neurochir Pol; 2019; 53(3):227-237. PubMed ID: 31180131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]